Companies Are Relying On Risk/Benefit Profile To Select Indications For Products, Kendle Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sicker patient populations are willing to tolerate more risk, allowing for a more generous risk/benefit profile, Kendle’s Sietsema says.